News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Rodriguez-Enriquez Sara
MitoPedia topics: EAGLE
Name | Rodriguez-Enriquez Sara, Dr., Investigador en Ciencias Medicas D |
---|---|
Institution | Department of Biochemistry,
National Institute of Cardiology, MX |
Address | Juan Badiano No. 1
Col. Seccion 16, 14080 |
City | Tlalpan |
State/Province | |
Country | Mexico |
[email protected] | |
Weblink | |
O2k-Network Lab | MX Mexiko City Moreno-Sanchez R |
Labels:
Publications
Published | Reference | |
---|---|---|
Robledo-Cadena 2024 PLoS One | 2024 | Robledo-Cadena DX, Pacheco-Velázquez SC, Vargas-Navarro JL, Padilla-Flores JA, López-Marure R, Pérez-Torres I, Kaambre T, Moreno-Sánchez R, Rodríguez-Enríquez S (2024) Synergistic celecoxib and dimethyl-celecoxib combinations block cervix cancer growth through multiple mechanisms. PLoS One 19:e0308233. https://doi.org/10.1371/journal.pone.0308233 |
Moreno-Sanchez 2022 MitoFit | 2022 | Moreno-Sánchez R, Robledo-Cadena DX, Pacheco-Velázquez SC, Rodríguez-Enríquez S (2022) Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect. https://doi.org/10.26124/mitofit:2022-0024 |
BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |
Robledo-Cadena 2020 Pharmaceuticals (Basel) | 2020 | Robledo-Cadena DX, Gallardo-Pérez JC, Dávila-Borja V, Pacheco-Velázquez SC, Belmont-Díaz JA, Ralph SJ, Blanco-Carpintero BA, Moreno-Sánchez R, Rodríguez-Enríquez S (2020) Non-steroidal anti-inflammatory drugs increase cisplatin, paclitaxel, and doxorubicin efficacy against human cervix cancer cells. Pharmaceuticals (Basel) 13:463. |
Rodriguez-Enriquez 2019 Toxicol Appl Pharmacol | 2019 | Rodríguez-Enríquez S, Pacheco-Velázquez SC, Marín-Hernández Á, Gallardo-Pérez JC, Robledo-Cadena DX, Hernández-Reséndiz I, García-García JD, Belmont-Díaz J, López-Marure R, Hernández-Esquivel L, Sánchez-Thomas R, Moreno-Sánchez R (2019) Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacol 370:65-77. |
Pacheco-Velazquez 2018 Mol Pharm | 2018 | Pacheco-Velázquez SC, Robledo-Cadena DX, Hernández-Reséndiz I, Gallardo-Pérez JC, Moreno-Sánchez R, Rodríguez-Enríquez S (2018) Energy metabolism drugs block triple negative breast metastatic cancer cell phenotype. Mol Pharm 15:2151-64. |
Hernandez-Resendiz 2018 J Cell Physiol | 2018 | Hernández-Reséndiz I, Gallardo-Pérez JC, López-Macay A, Robledo-Cadena DX, García-Villa E, Gariglio P, Saavedra E, Moreno-Sánchez R, Rodríguez-Enríquez S (2018) Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells. J Cell Physiol 234:5524-36. |
Corona de la Pena 2017 PLoS One | 2017 | Corona de la Peña N, Gutiérrez-Aguilar M, Hernández-Reséndiz I, Marín-Hernández Á, Rodríguez-Enríquez S (2017) Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets. https://doi.org/10.1371/journal.pone.0182374 |
Moreno-Sanchez 2013 FEBS J | 2013 | Moreno-Sánchez R, Hernández-Esquivel L, Rivero-Segura NA, Marín-Hernández A, Neuzil J, Ralph SJ, Rodríguez-Enríquez S (2013) Reactive oxygen species are generated by the respiratory Complex II - evidence for lack of contribution of the reverse electron flow in Complex I. FEBS J 280:927-38. |
Abstracts
Published | Reference | |
---|---|---|
Moreno-Sanchez 2022 Abstract Bioblast | 2022 | 6.2. «10+5» Moreno-Sanchez Rafael, Robledo-Cadena DX, Pacheco-Velázquez SC, Rodríguez-Enríquez S (2022) Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect. Bioblast 2022: BEC Inaugural Conference. In: https://doi.org/10.26124/bec:2022-0001 |